Federal contractor · CHICAGO, IL

CUBIT DIAGNOSTICS, INC

No contract obligations recorded for CUBIT DIAGNOSTICS, INC in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
MX5XL9PAEUB9
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 300KFY2024

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for CUBIT DIAGNOSTICS, INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

CUBIT DIAGNOSTICS, INC received $0 in federal assistance in FY2026, on 4 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
4
Since FY2025
$307K

Assistance by fiscal year

  1. 307KFY2025
  2. 0FY2026

Largest awards

  1. DEVELOPMENT OF AN ULTRASENSITIVE, RAPID AND PORTABLE NUCLEIC ACID BASED TEST FOR DETECTION OF ACUTE HEPATITIS C VIRUS INFECTION AT THE…$307K
    93.116 · Project Grants and Cooperative Agreements for Tuberculosis Control Programs· Centers for Disease Control and Prevention· Grant· Sep 12, 2025 – Jan 29, 2026· R43PS005313

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2025–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. PATHCISION MEDICINE, INC.$300K−115% in FY2026
    WATERTOWN, MA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. METACLIPSE THERAPEUTICS CORP$300K−115% in FY2026
    ATLANTA, GA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. ASO THERAPEUTICS, INC.$300K−115% in FY2026
    SAN RAFAEL, CA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.